Evotec and Spero Therapeutics Extend Collaboration to Develop Novel Antibacterials

Go back to Evotec and Spero Therapeutics Extend Collaboration to Develop Novel Antibacterials
EATON VANCE TAX-ADVANTAGED DIVIDEND INCOME FUND (NYSE: EVT) Delayed: 29.27 -0.15 (0.51%)
Previous Close $29.42    52 Week High $21.25 
Open $29.34    52 Week Low $16.37 
Day High $29.48    P/E N/A 
Day Low $29.10    EPS $0.00 
Volume 94,031       

EATON VANCE TAX-ADVANTAGED DIVIDEND INCOME FUND (NYSE: EVT) Delayed: 29.27 -0.15 (0.51%)
Previous Close $29.42    52 Week High $21.25 
Open $29.34    52 Week Low $16.37 
Day High $29.48    P/E N/A 
Day Low $29.10    EPS $0.00 
Volume 94,031       

Evotec Aktiengesellschaft American Depositary Share (AMEX: EVTCY) Delayed: 22.96 --0 (-0%)
Previous Close $22.96    52 Week High $11.93 
Open $22.96    52 Week Low $6.56 
Day High $22.96    P/E N/A 
Day Low $22.96    EPS $0.00 
Volume 1,020,350       

Muenchener Re Group AG Unsponsored ADR (AMEX: MURGY) Delayed: 12.07 +0.11 (0.92%)
Previous Close $11.96    52 Week High $20.93 
Open $12.07    52 Week Low $15.56 
Day High $12.19    P/E N/A 
Day Low $12.04    EPS $0.00 
Volume 3,706,436